Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05244187 · ClinicalTrials.gov registry record · NA

Study to Evaluate the OrthoCor Active System for Pain Relief

A NA study of Pain, sponsored by Caerus Corporation.

Completed
Registry status
NA
Development phase
120
Enrollment target
5
Study locations

NCT05244187: Completed NA study of Pain, sponsored by Caerus Corporation.

NCT05244187 is a NA study of Pain that has completed, run by Caerus Corporation. The registered enrollment target is 120 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower). The trial reports 5 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05244187, a NA study of Pain, has completed, sponsored by Caerus Corporation.

COMPLETED
Registry status
NA
Development phase
120 participants
Enrollment target
5
Study locations

Study Summary

This is a prospective, multi-center, randomized, pivotal study to evaluate the OrthoCor Active System in individuals prescribed its use in comparison with the standard of care intervention for pain relief.

Conditions Studied

Interventions

  • DEVICE OrthoCor Active System

Study Locations (5)

New York

  • Orlin & Cohen Orthopedic Group - Smithtown
  • Spinal Pain and Rehabilitation Medicine - Yonkers

Florida

  • Andrews Research & Education Foundation - Gulf Breeze

Michigan

  • GFC of Southeastern Michigan PC - Detroit

New Jersey

  • Rothman Orthopedic Institute - Washington Township

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-11-07
Est. Completion 2023-11-23
Phase NA

Sponsor

Caerus Corporation

2 total trials

What the Registry Record Tells You About NCT05244187

The ClinicalTrials.gov registry entry for NCT05244187 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (61% lower). The listed sponsor is Caerus Corporation, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 1 intervention - of which OrthoCor Active System is the first listed.

NCT05244187 reports 5 study locations spanning 4 distinct geographic areas - top geographies include New York, Florida, Michigan.

Frequently Asked Questions

What is clinical trial NCT05244187 about?

NCT05244187 is a clinical study titled "Study to Evaluate the OrthoCor Active System for Pain Relief". This is a prospective, multi-center, randomized, pivotal study to evaluate the OrthoCor Active System in individuals prescribed its use in comparison with the standard of care intervention for pain relief.

What is the current status of trial NCT05244187?

This trial is currently completed. It is a NA study. The enrollment target is 120 participants. The study started on 2022-11-07. Estimated completion is 2023-11-23.

What conditions does trial NCT05244187 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT05244187?

The interventions under investigation include: OrthoCor Active System (DEVICE).

Who is sponsoring clinical trial NCT05244187?

This trial is sponsored by Caerus Corporation, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05244187 being conducted?

This trial has 5 study locations across Florida, Michigan, New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.